ANI Pharmaceuticals Statistics

Total Valuation

BST:BSFA has a market cap or net worth of EUR 1.11 billion. The enterprise value is 1.54 billion.

Market Cap	1.11B
Enterprise Value	1.54B

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	20.02M
Shares Outstanding	n/a
Shares Change (YoY)	+2.79%
Shares Change (QoQ)	+3.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	15.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	10.09
PS Ratio	1.78
PB Ratio	2.71
P/TBV Ratio	n/a
P/FCF Ratio	18.03
P/OCF Ratio	14.87
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.43, with an EV/FCF ratio of 24.92.

EV / Earnings	-73.99
EV / Sales	2.68
EV / EBITDA	19.43
EV / EBIT	124.01
EV / FCF	24.92

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 1.42.

Current Ratio	2.66
Quick Ratio	1.86
Debt / Equity	1.42
Debt / EBITDA	6.77
Debt / FCF	9.46
Interest Coverage	0.45

Financial Efficiency

Return on equity (ROE) is -4.57% and return on invested capital (ROIC) is 0.99%.

Return on Equity (ROE)	-4.57%
Return on Assets (ROA)	0.82%
Return on Invested Capital (ROIC)	0.99%
Return on Capital Employed (ROCE)	1.34%
Revenue Per Employee	695,259
Profits Per Employee	-23,137
Employee Count	897
Asset Turnover	0.61
Inventory Turnover	2.18

Taxes

Income Tax	-6.02M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.03% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.03%
50-Day Moving Average	55.12
200-Day Moving Average	54.82
Relative Strength Index (RSI)	50.59
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.31

Income Statement

In the last 12 months, BST:BSFA had revenue of EUR 623.65 million and -20.75 million in losses. Loss per share was -1.07.

Revenue	623.65M
Gross Profit	370.06M
Operating Income	13.48M
Pretax Income	-25.50M
Net Income	-20.75M
EBITDA	83.73M
EBIT	13.48M
Loss Per Share	-1.07

Full Income Statement

Balance Sheet

The company has 143.58 million in cash and 582.73 million in debt, giving a net cash position of -439.15 million.

Cash & Cash Equivalents	143.58M
Total Debt	582.73M
Net Cash	-439.15M
Net Cash Per Share	n/a
Equity (Book Value)	410.30M
Book Value Per Share	19.34
Working Capital	309.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 74.70 million and capital expenditures -13.07 million, giving a free cash flow of 61.63 million.

Operating Cash Flow	74.70M
Capital Expenditures	-13.07M
Free Cash Flow	61.63M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.34%, with operating and profit margins of 2.16% and -3.12%.

Gross Margin	59.34%
Operating Margin	2.16%
Pretax Margin	-4.09%
Profit Margin	-3.12%
EBITDA Margin	13.43%
EBIT Margin	2.16%
FCF Margin	9.88%

Dividends & Yields

BST:BSFA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.79%
Shareholder Yield	n/a
Earnings Yield	-1.87%
FCF Yield	5.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BST:BSFA has an Altman Z-Score of 1.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.62
Piotroski F-Score	3